Source: Benzinga

Delphinus: DELPHINUS MEDICAL TECHNOLOGIES AND AUSTIN RADIOLOGICAL ASSOCIATION MARK MILESTONE IN ADVANCED SCREENING FOR WOMEN WITH DENSE BREASTS

Novi, Michigan, March 28, 2025 (GLOBE NEWSWIRE) -- Delphinus Medical Technologies and Austin Radiological Association (ARA) proudly announce the success of ARA's SoftVue screening program, launched in December at their Cedar Park location. As the only FDA-approved breast ultrasound tomography system for supplemental screening in asymptomatic women with dense breast tissue, SoftVue has been making a meaningful impact in the fight against breast cancer. By integrating SoftVue into its imaging services, ARA has raised the standard of patient care and satisfaction by offering a reimbursable supplemental screening option tailored for women with dense breasts."ARA has always been a leader in providing advanced imaging technology that truly improves the patient experience," commented Arthy Saravanan, MD. "The adoption of SoftVue provides expanded screening capabilities for women with dense breasts while also elevating patient comfort, which will likely lead to higher annual compliance rates for patient screening."In the United States, up to 40% of women have dense breast tissue, which can complicate early detection and increase the risk of developing breast cancer. In response to this clinical challenge, SoftVue was developed to ...Full story available on Benzinga.com

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Scott A. White's photo - President & CEO of Delphinus

President & CEO

Scott A. White

CEO Approval Rating

85/100

Read more